Karyopharm Therapeutics Competitors and Similar CompaniesClear all

Karyopharm Therapeutics's competitors and similar companies include Apeloa Pharmaceutical, Faes Farma and STADA.

	Karyopharm Therapeutics Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies.	Apeloa Pharmaceutical Apeloa Pharmaceutical (普洛药业股份有限公司) is a company that develops and produces pharmaceutical products.	Faes Farma Faes Farma is a pharmaceutical company that develops, produces and commercializes pharmaceutical products and raw materials.	STADA STADA Arzneimittel is a company engaged in the healthcare and pharmaceuticals business.
Founding Date	Founding Date 2008	Founding Date 1989	Founding Date 1933	Founding Date 1895
Type	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare drug development healthtech pharma	Tags Healthcare drug development healthtech pharma	Tags Healthcare drug development healthtech pharma	Tags Healthcare drug development healthtech pharma
Locations	Locations Newton, US HQ Givatayim, IL	Locations CN HQ	Locations Leioa, ES HQ Madrid, ES Atlanta, US	Locations Bad Vilbel, DE HQ Beijing, CN Hangzhou Shi, CN Shanghai, CN Bad Vilbel, DE Budapest, HU Vilnius, LT see more
Employees	Employees 22818% decrease	Employees 7,060	Employees 1,775	Employees 12,33911% increase
Valuation ($)	Valuation ($) 111.7 m	Valuation ($) 2.7 b	Valuation ($) 1.2 b	Valuation ($) 6 b
Financial
Revenue (est.)	Revenue (est.) $146.1m (FY, 2025)	Revenue (est.) ¥9.7b (FY, 2025)	Revenue (est.) €493.6m (FY, 2024)	Revenue (est.) €3b (FY, 2020)
Cost of goods	Cost of goods $5.9m (FY, 2025)	Cost of goods ¥7.2b (FY, 2025)	Cost of goods €167.1m (FY, 2024)	Cost of goods €1.3b (FY, 2020)
Gross profit	Gross profit $140.1m (FY, 2025)	Gross profit ¥2.5b (FY, 2025)	Gross profit €342.9m (FY, 2024)	Gross profit €1.7b (FY, 2020)
Net income	Net income ($196m) (FY, 2025)	Net income ¥890.7m (FY, 2025)	Net income €111.1m (FY, 2024)	Net income €181.9m (FY, 2020)